Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125631131 | 12563113 | 1 | I | 20160702 | 20160715 | 20160715 | EXP | US-BAUSCH-BL-2016-015861 | BAUSCH AND LOMB | HOFMANN M, OVERMAN M, NATES J. ACUTE BENZODIAZEPINE TOXICITY EXACERBATED BY CONCOMITANT ORAL OLANZAPINE. THE JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY. 2016;14:178-179. | 61.00 | YR | F | Y | 0.00000 | 20160715 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125631131 | 12563113 | 1 | PS | LORAZEPAM. | LORAZEPAM | 1 | Oral | U | 17794 | 1 | MG | ||||||||
| 125631131 | 12563113 | 2 | I | LORAZEPAM. | LORAZEPAM | 1 | Intravenous (not otherwise specified) | U | 17794 | 1 | MG | ||||||||
| 125631131 | 12563113 | 3 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 10 | MG | ||||||||
| 125631131 | 12563113 | 4 | SS | OLANZAPINE. | OLANZAPINE | 1 | U | 0 | |||||||||||
| 125631131 | 12563113 | 5 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | OVER 2 HOURS | 0 | 60 | MG/M**2 | ||||||||
| 125631131 | 12563113 | 6 | C | FUOROURACIL | 2 | Intravenous (not otherwise specified) | OVER 46 HOURS | 0 | 2000 | MG/M**2 | |||||||||
| 125631131 | 12563113 | 7 | C | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125631131 | 12563113 | 1 | Anxiety |
| 125631131 | 12563113 | 2 | Nausea |
| 125631131 | 12563113 | 3 | Vomiting |
| 125631131 | 12563113 | 4 | Nausea |
| 125631131 | 12563113 | 5 | Pancreatic carcinoma metastatic |
| 125631131 | 12563113 | 6 | Pancreatic carcinoma metastatic |
| 125631131 | 12563113 | 7 | Pancreatic carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125631131 | 12563113 | HO |
| 125631131 | 12563113 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125631131 | 12563113 | Delirium | |
| 125631131 | 12563113 | Drug interaction | |
| 125631131 | 12563113 | Hypotension | |
| 125631131 | 12563113 | Respiratory depression | |
| 125631131 | 12563113 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |